Criteria
| Eligible Active Ingredient: | Alcaftadine. As eyedrops not exceeding 0.25% |
| With Effective From: | 1-Jun-17 |
| Indication Permitted: | Prevention of itching associated with allergic conjunctivitis |
| Maximum Daily Dose: | One drop into affected eye once daily |
| Maximum Supply per Transaction: | 3ml |
| Minimum Age of User: | 3 years |
| Patient Information Leaflet from HSA/PSS: | Download PIL (Link to HSA website) |
Mechanism of Action of Alcaftadine
Alcaftadine is a H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.
Additional Information of Alcaftadine
| Pharmacology Class: | Decongestants And Antiallergics |
| Therapeutic Class: | Ophthalmologicals |
| Chemical Class: | Other Antiallergics |
| Synonyms: | 6,11-Dihydro-11-(1-Methyl-4-piperidinylidene)-5H-iMidazo[2,1-b][3]benzazepine-3-carboxaldehyde | Alcaftadina | Alcaftadinum | Vilasta |
Show All HSA-registered therapeutic products granted exemption to supply without prescription
References
HSA-Registered Products Containing Alcaftadine As eyedrops not exceeding 0.25%
wpDataTable with provided ID not found!
This list is not exhaustive. HSA collaborates with Pharmaceurical Society of Singapore (PSS) to review the appropriate use of therapeutic products in the community from time to time. Hence, HSA may enable the supply of a Prescription Only Medicine (POM) by pharmacists without a prescription, upon review that the product can be used in a safe and effective manner under the supervision of a pharmacist. This can be effected through legislative mechanisms in the absence of an application made by the product registrant to reclassify the therapeutic product, subject to to conditions including indication, strength, maximum daily dose, maximum supply quantity, and age restriction.